Is insulin resistance linked to hypertension?

Clinical and Experimental Pharmacology and Physiology

Volumn 25, Issue 1, 1998, Pages 70-76

  Brands, Michael W ^a   Hall, John E ^a   Keen, Henry L ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Blood flow; Blood pressure; Hypertension; Insulin; Insulin resistance; Obesity; Pressure natriuresis; Sodium excretion; Vasoconstriction

Indexed keywords

INSULIN; SODIUM;

BLOOD FLOW; CONFERENCE PAPER; ESSENTIAL HYPERTENSION; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; MORBIDITY; NATRIURESIS; OBESITY; SKELETAL MUSCLE; VASCULAR RESISTANCE; VASODILATATION;

EID: 0031931748     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1998.tb02148.x     Document Type: Conference Paper

References (67)

1. Benedict FG, Roth P. Effect of a prolonged reduction in diet on twenty-five men. Proc. Natl Acad. Sci. USA 1918; 4: 149-56.
2. Huber EG. Systolic blood pressure of healthy adults in relation to body weight. JAMA 1927; 88: 1554-9.
3. Chiang BN, Perlman LV, Epstein FH. Overweight and hypertension. Circulation 1969; 39: 403-21.
4. Berglund G, Larsson B, Andersson O et al. Body composition and glucose metabolism in hypertensive middle-aged males. Acta Med. Scand. 1976; 200: 163-9.
5. Kannel WB, Brand N, Skinner JJ. The relation of adiposity to blood pressure and development of hypertension: The Framingham Study. Ann. Intern. Med. 1967; 67: 48-59.
6. DeFronzo RA, Soman V, Sherwin RS, Hendler R, Felig P. Insulin binding to monocytes and insulin action in human obesity, starvation, and refeeding. J. Clin. Invest. 1978; 62: 204-13.
7. Sims EAH, Danforth E, Horton ES, Bray GA, Glennon JA, Salans LB. Endocrine and metabolic effects of experimental obesity in man. Rec. Prog. Hormone Res. 1973; 29: 457-87.
8. Stanik S, Marcus R. Insulin secretion improves following dietary control of plasma glucose in hyperglycemic obese patients. Metabolism 1980; 29: 346-50.
9. Reisin E, Abel R, Modan M, Silverberg DS, Eliahou HE, Modan B. Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. N. Engl. J. Med. 1978; 298: 1-6.
10. DeFronzo RA. The effect of insulin on renal sodium metabolism. Diabetologia 1981; 21: 165-71.
11. Dahl LK, Silver L, Christie RW. The role of salt in the fall of blood pressure accompanying reduction in obesity. N. Engl. J. Med. 1958; 258: 1186-92.
12. Atchley DW, Loeb RF, Richards DW, Benedict EM, Driscoll ME. On diabetic acidosis. J. Clin. Invest. 1933; 12: 297-326.
13. Miller JH, Bogdonoff MD. Antidiuresis associated with administration of insulin. J. Appl. Physiol. 1954; 6: 509-12.
14. DeFronzo RA, Cooke CR, Andres R, Faloona GR, Davis PJ. The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J. Clin. Invest. 1975; 55: 845-55.
15. Sowers JR, Whitfield LA, Catinia RA et al. Role of the sympathetic nervous system in blood pressure maintenance in obesity. J. Clin. Endocrinol. Metab. 1982; 54: 1181-6.
16. Dornfeld LP, Maxwell MH, Waks A, Tuck M. Mechanisms of hypertension in obesity. Kidney Int. 1987; 32 (Suppl. 22): S254-8.
17. Anderson EA, Hoffman RP, Balon TW, Sinkey C, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J. Clin. Invest. 1991; 87: 2246-52.
18. Hall JE, Coleman TG, Mizelle HL, Smith MJ Jr. Chronic hyperinsulinemia and blood pressure regulation. Am. J. Physiol. 1990; 258: F722-31.
19. Hall JE, Brands MW, Kivlighn SD, Mizelle HL, Hildebrandt DA, Gaillard CA. Chronic hyperinsulinemia and blood pressure: Interaction with catecholamines? Hypertension 1990; 15: 519-27.
20. Brands MW, Mizelle HL, Gaillard CA, Hildebrandt DA, Hall JE. The hemodynamic response to chronic hyperinsulinemia in conscious dogs. Am. J. Hypertens. 1991; 4: 164-8.
21. Hwang I-S, Ho H, Hoffman BB, Reaven GM. Fructose-induced insulin resistance and hypertension in rats. Hypertension 1987; 10: 512-16.
22. Reaven GM, Ho H, Hoffman BB. Somatostatin inhibition of fructose-induced hypertension. Hypertension 1989; 14: 117-20.
23. Brands MW, Hildebrandt DA, Mizelle HL, Hall JE. Sustained hyperinsulinemia increases arterial pressure in conscious rats. Am. J. Physiol. 1991; 260: R764-8.
24. Brands MW, Hildebrandt DA, Mizelle HL, Hall JE. Hypertension during chronic hyperinsulinemia in rats is not salt-sensitive. Hypertension 1992; 19 (Suppl. I): I-83-9.
25. Brands MW, Garrity AC, Holman MG, Hall JE. Exaggerated pressor and chronotropic response to chronic hyperinsulinemia in SH versus WKY rats. Am. J. Hypertens. 1994; 7: 75-81.
26. Brands MW, Harrison DL, Keen HL, Gardner AL, Shek EW, Hall JE. Insulin-induced hypertension in rats is dependent on an intact renin-angiotensin system. Hypertension 1997; 29: 1014-19.
27. Brands MW, Lee WF, Keen HL, Alonso-Galicia M, Zappe D, Hall JE. Cardiac output and renal function during insulin hypertension in Sprague-Dawley rats. Am. J. Physiol. 1996; 271: R276-81.
28. Keen HL, Brands MW, Alonso-Galicia M, Hall JE. Chronic adrenergic receptor blockade does not prevent hyperinsulinemia-induced hypertension in rats. Am. J. Hypertens. 1996; 9: 1192-9.
29. Tomiyama H, Kushiro T, Abeta H et al. Blood pressure response to hyperinsulinemia in salt-sensitive and salt-resistant rats. Hypertension 1992; 20: 596-600.
30. Meehan WP, Buchanan TA, Hsueh W. Chronic insulin administration elevates blood pressure in rats. Hypertension 1994; 23: 1012-17.
31. Keen HL, Brands MW, Smith MJ Jr, Shek EW, Hall JE. Inhibition of thromboxane synthesis attenuates insulin-hypertension in rats. Am. J. Hypertens. 1997 (in press).
32. Anderson EA, Mark AL. The vasodilator action of insulin: Implications for the insulin hypothesis of hypertension. Hypertension 1993; 21: 136-41.
33. Dela F, Larsen JJ, Mikines KJ, Galbo H. Normal effect of insulin to stimulate leg blood flow in NIDDM. Diabetes 1995; 44: 221-6.
34. Utriainen T, Malmstrom R, Makimattila S, Yki-Jarvinen H. Methodological aspects, dose-response characteristics and causes of interindividual variation in insulin stimulation of limb blood flow in normal subjects. Diabetologia 1995; 38: 555-64.
35. Utriainen T, Holmang A, Bjorntorp P et al. Physical fitness, muscle morphology, and insulin-stimulated limb blood flow in normal subjects. Am. J. Physiol. 1996; 270: E905-11.
36. Laakso M, Edelman SV, Brechtel G, Baron AD. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. J. Clin. Invest. 1990; 85: 1844-52.
37. Tsutsu N, Nunoi K, Kodama T, Nomiyama R, Iwase M, Fujishima M. Lack of association between blood pressure and insulin in patients with insulinoma. J. Hypertens. 1990; 8: 479-82.
38. DeFronzo RA. Pathogenesis of type 2 diabetes mellitus: A balanced overview. Diabetologia 1992; 35: 389-97.
39. Pitre M, Nadeau A, Bachelard H. Insulin sensitivity and hemodynamic responses to insulin in Wistar-Kyoto and spontaneously hypertensive rats. Am. J. Physiol. 1996; 271: E658-68.
40. Rocchini AP, Wilson RF, Marker P, Cervanka T. Metabolic and hemodynamic effects of a graded intracoronary insulin infusion in normal and fat anesthetized dogs: A preliminary study. Hypertension 1996; 27: 354-9.
41. Hall JE, Brands MW, Zappe DH et al. Hemodynamic and renal responses to chronic hyperinsulinemia in obese, insulin-resistant dogs. Hypertension 1995; 25: 994-1002.
42. Guyton AC. Arterial Pressure and Hypertension. WB Saunders Co., Philadelphia. 1980.
43. Guyton AC. Long-term arterial pressure control: An analysis from animal experiments and computer and graphic models. Am. J. Physiol. 1990; 259: R865-77.
44. Huang M, Hester RL, Coleman TG, Smith MJ, Guyton AC. Development of hypertension in animals with reduced total peripheral resistance. Hypertension 1992; 20: 828-33.
45. Hall JE, Mizelle HL, Hildebrandt DA, Brands MW. Abnormal pressure natriuresis: A cause or a consequence of hypertension? Hypertension 1990; 15: 547-59.
46. Folkow B, Hallback M, Lundgren Y, Sivertsson B, Weiss L. Importance of adaptive changes in vascular design for establishment of primary hypertension, studied in man and in spontaneously hypertensive rats. Circ. Res. 1973; 32/33 (Suppl. I): I-2-38.
47. Hall JE, Brands MW, Mizelle HL, Gaillard CA, Hildebrandt DA. Chronic intrarenal hyperinsulinemia does not cause hypertension. Am. J. Physiol. 1991; 260: F663-9.
48. Hall JE, Brands MW, Dixon WN, Smith MJ Jr. Obesity-induced hypertension: Renal function and systemic hemodynamics. Hypertension 1995; 25: 994-1002.
49. Ferrannini E, Buzzigoli G, Bonadonna R et al. Insulin resistance in essential hypertension. N. Engl. J. Med. 1987; 317: 350-7.
50. Sowers JR, Standley PR, Ram JL, Zemel MB, Resnick LM. Insulin resistance, carbohydrate metabolism, and hypertension. Am. J. Hypertens. 1991; 4: S466-72.
51. Ferrannini E, Haffner SM, Stern MP. Essential hypertension: An insulin-resistant state. J. Cardiovasc. Pharmacol. 1990; 15 (Suppl. 5): S18-25.
52. Hall JE, Summers RL, Brands MW, Keen H, Alonso-Galicia M. Resistance to metabolic actions of insulin and its role in hypertension. Am. J. Hypertens. 1994; 7: 772-88.
53. Denker PS, Pollock VE. Fasting serum insulin levels in essential hypertension: A meta-analysis. Arch. Intern. Med. 1992; 152: 1649-51.
54. Weir MR. Insulin resistance and salt sensitivity: A renal hemodynamic abnormality? Am. J. Hypertens. 1996; 9: S193-9.
55. Verma S, Bhanot S, McNeill JH. Metformin decreases plasma insulin levels and systolic blood pressure in spontaneously hypertensive rats. Am. J. Physiol. 1994; 267: H1250-3.
56. Xhang HY, Reddy SR, Kotchen TA. Antihypertensive effect of pioglitazone is not invariably associated with increased insulin sensitivity. Hypertension 1994; 24: 106-10.
57. Kotchen TA. Attenuation of hypertension by insulin-sensitizing agents. Hypertension 1996; 28: 219-23.
58. Natali A, Galvan AQ, Arzilli F et al. Renovascular hypertension and insulin sensitivity. Eur. J. Clin. Invest. 1996; 26: 556-63.
59. Zhang F, Sowers JR, Ram JL, Standley PR, Peuler JD. Effects of pioglitazone on calcium channels in vascular smooth muscle. Hypertension 1994; 24: 170-5.
60. Bhalla RC, Toth KF, Tan E, Bhatty RA, Mathias E, Sharma RV. Vascular effects of metformin. Am. J. Hypertens. 1996; 9: 570-6.
61. Howes LG, Sundaresan P, Lykos D. Cardiovascular effects of oral hypoglycaemic drugs. Clin. Exp. Pharm. Physiol. 1996; 23: 201-6.
62. Julius S, Gudbrandsson T, Jamerson K, Shahab ST, Andersson O. The hemodynamic link between insulin resistance and hypertension. J. Hypertens. 1991; 9: 983-6.
63. Ferrannini E. Insulin and blood pressure: Possible role of hemodynamics. Clin. Exp. Hypertens. Theory Practice 1992; A14: 271-84.
64. Cowley AW Jr. Long-term control of arterial blood pressure. Physiol. Rev. 1992; 72: 231-300.
65. Natali A, Bonadonna R, Santoro D et al. Insulin resistance and vasodilation in essential hypertension: Studies with adenosine. J. Clin. Invest. 1994; 94: 1570-6.
66. Widgren BR, Urbanavicius V, Wikstrand J, Attvall S, Persson B. Lowdose angiotensin II increases glucose disposal rate during euglycemic hyperinsulinemia. Am. J. Hypertens. 1993; 6: 892-5.
67. Rao RH. Effects of angiotensin II on insulin sensitivity and fasting glucose metabolism in rats. Am. J. Hypertens. 1994; 7: 655-60.